MYOD1 and neoplasm: The most recent edition of the WHO Classification of Tumours, Soft Tissue and Bone Tumours now includes a histologic type encompassing the spindle cell/sclerosing subtypes of RMS, a subset of which harbor MYOD1 L122R point mutations and have particularly aggressive clinical behavior and inferior outcomes7.